Senate Introduces Bill To Track Implant Failure Rates

Bernstein Liebhard LLP endorses a new bill that would force medical device manufacturers to track the performance of implants, including artificial hips and vaginal mesh. New York, NY (PRWEB) December 16, 2011 Bernstein Liebhard LLP reports that on December 14, 2011, new legislation was introduced in the Senate that would require medical device manufacturers to track the performance of implants.* The bill would allow the U.S. Food and Drug Administration (“FDA”) to compel manufacturers to track implants after they are approved for sale. Currently, medical device manufacturers can bypass
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations